Skip to content

Biosfer Teslab

Biosfer Teslab obtains a grant from ICEX Next programme

ICEX Next internationalisation programme The ICEX Next programme aims to promote the internationalisation of Spanish companies and their confidence in foreign markets. The ICEX Internationalization programme, aims to help and internationalize the business, in order to increase turnover abroad, reduce business risk and increase global competitiveness. The programme, aimed at any Spanish SME that has… Read More »Biosfer Teslab obtains a grant from ICEX Next programme

ICEX Next

Biosfer Teslab present at the Metabolomics 2022 congress

Biosfer Teslab presents at Metabolomics 2022 The 18th Annual Conference of the Metabolomics Society – Metabolomics 2022 took place in Valencia from 19 to 23 June. The event brought together hundreds of scientists from around the world who presented the latest technological and bioinformatics advances in the field of metabolomics, as well as its application… Read More »Biosfer Teslab present at the Metabolomics 2022 congress

biosfer Teslab en metabolomics

Biosfer Teslab Award for Innovation and Digitalisation Tarragona 2022

Innovation and Digitalisation Award 2022 Tarragona In recognition of the great work carried out by small and medium-sized enterprises as generators of wealth and creators of employment in the performance of their daily work, Banco Santander, Cámara de Comercio de Tarragona and the Cámara de Comercio de Reus, in collaboration with the Cámara de España… Read More »Biosfer Teslab Award for Innovation and Digitalisation Tarragona 2022

premio innovación

Biosfer Teslab participates in precision medicine forum

The Precision Medicine Forum In February this year, the Valdecilla Health Research Institute (IDIVAL) launched the “International Precision Medicine Forum“, supported by the ITEMAS platform, the Biobanks and Biomodels platform and the Spanish Society of Clinical Pharmacology. The forum, with the participation of more than a hundred experts, aims to review, from the point of… Read More »Biosfer Teslab participates in precision medicine forum

Precision medicine

Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of Liver Diseases (AASLD). The mission of the association is to advance and disseminate the science and practice of hepatology, and to promote liver health. This year, Biosfer Teslab, together with OWL Metabolomics, University of Medicine… Read More »Metabolomics arrives at “The liver Meeting” comes from Biosfer Teslab

Metabolòmica al the Liver meeting

Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

One of the key features of malignant tumour cells is that their energy metabolism is altered. However, in recent years, alterations in lipid metabolism have been described in some types of cancer. A study led by the team of Dr. Josep Gumà and Dr. Sandra Guaita from the Pere Virgili Health Research Institute (IISPV) and… Read More »Liposcale for early and reliable diagnosis and prognosis of breast cancer patients

Liposcale Breast cancer

Liposcale in Circulation

Frequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small studies have shown that supplementing the diet with nuts has a considerable effect on reducing dietary cholesterol in the short term, there is little information… Read More »Liposcale in Circulation

Liposcale in Circulation

Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical Kidney journal, conducted in patients with chronic kidney disease, reveals that information on lipoprotein composition and subclass particle number using the Liposcale test could improve… Read More »Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test

malaltia cardiovascular ateromatosa

Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the IISPV, the URV and the spin-off Biosfer Teslab, SL. The call granted has been “Replegar-se per crèixer: l’impacte de les pandèmies en un món sense… Read More »Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.

Covid-19